The Mini-Fellowship › Curriculum

The curriculum, module by module

Fifteen modules over four days, each mapped to what a participant should be able to do at the end of the program, with the clinical sessions, the competency assessment and the mentorship year that follow.

The course director teaching beside the infusion chair
Modules15, plus three clinical sessions
DaysThursday to Sunday, 8:30 AM–4:00 PM, finishing 2:00 PM Sunday
TeachingSmall seminar, four clinicians
ClinicalSupervised peer practicum
AssessmentModule 15: examination and observation
After12 months of mentorship

Doing ketamine-assisted psychotherapy? Held in the anxiolytic–empathogenic range, the patient’s ego defenses are relaxed and they are set back from the emotion of the situation — able and willing to engage for the working part of the session, instead of in fragments around a peak. That is this method, applied to a KAP session. See what that looks like

How the curriculum is organized

Three kinds of learning, over four days.

Each morning is a seminar for four clinicians: the material is taught in discussion, with questions taken as they arise and time set aside for each participant’s own practice setting and state requirements. Each afternoon moves into the infusion suite, where the morning’s material is performed rather than described.

The modules build in sequence. Days 1 and 2 establish the science, the regulation and the safety systems, and reach the chair. Day 3 adds the variables that decide who responds and how. Day 4 turns all of it into the method the program is built around, and ends with the competency assessment. Nothing is assessed that was not taught and practiced.

The curriculum is reviewed as new guidance is published. Where published recommendations differ, the course teaches to the more protective of them.

Day 1

Modules 1–4 · The clinical skills labScience, regulation, controlled substances and practice setup.

Day 2

Modules 5–9 · The peer practicum beginsWhy standards matter, pharmacokinetics, mechanism, delivery and risk, and target-determined infusion.

Day 3

Modules 10–12 · The practicum continuesThe critical variables, metabolism and genetics, and the SOMA framework.

Day 4

Modules 13–15 · Examination and competency assessmentDosing trajectories, the tools and documentation you take home, then the assessment.

Experiential

An optional, fully monitored personal infusionTwo participants on Day 2, two on Day 3. Voluntary and separately consented.

Mentorship

Twelve months, with quarterly milestones and a re-assessment

What the curriculum is built to produce

Ten objectives. Every module serves at least one.

Each module below lists the objectives it serves, and the reading that supports it. The numbers match this list.

  1. Explain ketamine’s pharmacology as an anesthetic agent
  2. Select and evaluate candidates for infusion therapy
  3. Stratify infusion risk before the first dose
  4. Calculate an infusion from a target plasma concentration
  5. Interpret pharmacogenomic results
  6. Monitor continuously and apply discharge criteria
  7. Manage airway and hemodynamic events
  8. Prepare and guide a patient through the experience
  9. Run controlled-substance, consent and quality systems
  10. Measure response and plan the next course

Day 1 · Thursday

Foundations, compliance and practice setup

Modules 1–4 in the morning seminar, then the afternoon in the infusion suite. The full day in detail →

Module1

The Scientific Journey of Ketamine

Where the drug and its dosing protocol came from: anesthesia in the 1960s, FDA approval in 1970, the volunteer studies of the 1990s, and the two small antidepressant trials whose 0.5 mg/kg over forty minutes became the default. The module closes on what that inheritance does and does not support.

Objectives 01Reading 1, 2, 3, 4
Module2

Clinical Excellence, Regulatory Compliance and Medical-Legal Standards

The rules a ketamine practice answers to: federal controlled-substance law, state medical-board requirements, published consensus guidance and nursing scope statements. Patient selection and contraindications, baseline testing, consent as a documented conversation, and the records a board or a malpractice carrier will ask to see.

Objectives 02 · 09Reading 5
Module3

DEA Compliance and Controlled-Substance Management

Running the controlled-substance program so that it is ready for an inspection on any given day: logbooks kept in real time, vial serialization and secure storage, two-person waste and Form 41, procurement and reporting, and prescription-monitoring checks at intake and quarterly.

Objectives 09
Module4

Setting Up Your Infusion Practice

The physical practice: suite layout and size, staffing and roles, monitors, pumps and the emergency cart, what must be in the room throughout an infusion and who must be immediately available. Start-up costs and a readiness checklist, with the state rule governing wherever it is stricter.

Objectives 06 · 07 · 09

Day 2 · Friday

Pharmacokinetics and supervised practice

Modules 5–9 in the morning seminar, then the afternoon in the infusion suite. The full day in detail →

Module5

The Future of Ketamine Therapy: Why Standards Matter

What outcomes look like outside clinical trials, what telehealth prescribing and compounded ketamine have changed, and why the field is moving from a fixed weight-based dose toward concentration targeting. Also how meeting your own state’s requirements supports referral relationships.

Objectives 01 · 10Reading 6
Module6

Pharmacokinetics and Plasma Concentrations

Why the same milligram-per-kilogram dose reaches different plasma levels in different patients: volume of distribution and clearance, and how much they vary between people. Introduces peak concentration, the minimum effective and maximum tolerated concentrations, and adjusted body weight for patients with a BMI of 30 or more.

Objectives 04Reading 7, 11
Module7

Mechanism of Action: The Master Molecule

What ketamine does, from receptor to network: the two enantiomers and their active metabolites, NMDA blockade and the glutamate surge, the neuroplasticity cascade, and the network models behind depression and chronic neuropathic pain.

Objectives 01Reading 8
Module8

Mastery of Delivery and Risk Management

Route selection and the risks that follow from it, with neurological, cardiovascular, respiratory and hepatic profiles; baseline testing; preventive and rescue medication; managing dissociation and blood pressure in real time; airway problems; and the long-term questions of misuse, cognition and bladder symptoms.

Objectives 04 · 07
Module9

Advanced Pharmacokinetics and Target-Determined Infusions

Turning the principles into a working model: the three-compartment model, how infusion rate relates to receptor occupancy and peak concentration, the KRI infusion dataset behind the reference targets, and the Clinical Companion used at the chair. Includes the published dosing parameters for chronic pain.

Objectives 04Reading 11, 12, 13

Day 3 · Saturday

The critical variables and patient selection

Modules 10–12 in the morning seminar, then the afternoon in the infusion suite. The full day in detail →

Module10

Transforming Your Approach: The Critical Variables

The five variables that decide how a dose behaves in a particular patient — mass, metabolism, medications, morbidities and mindset — with medication reconciliation in treatment-resistant depression and the interactions that blunt or amplify the response.

Objectives 04 · 05
Module11

Metabolism, Genetics and Comorbidity Management

Which genetic and metabolic findings matter and when they should change the plan: CYP450 activity and common variants, pharmacogenomic testing in practice, and correctable comorbidities such as thyroid, testosterone, magnesium and carnitine status.

Objectives 05Reading 9
Module12

Precision Medicine in Practice: The SOMA Framework

The workflow that holds the course together: Selection, Optimization, Monitoring and Adjustment. Eligibility and red flags, structured optimization before treatment begins, tolerance and tachyphylaxis, when to continue and when to stop, and coordination with the patient’s mental-health team.

Objectives 02 · 03 · 10

Day 4 · Sunday

Dosing, documentation and certification

Modules 13–15 in the morning seminar, then the afternoon in the infusion suite. The full day in detail →

Module13

Personalized Dosing and Treatment Trajectories

Setting the target by diagnosis and following a patient through a series: the levels of consciousness, the induction, reinforcement and maintenance stages, biometric feedback during the infusion, and the validated scales used at every session.

Objectives 04 · 10
Module14

Putting It All Together: Tools, Quality and Professional Accountability

The systems a defensible practice runs on: point-of-care references and standard operating procedures written for your own site, adverse-event reporting, quality review of outcomes and complications, and the ethical and medical-legal obligations that come with off-label psychiatric care.

Objectives 09 · 10
Module15

Competency Assessment and Certification

The assessment itself: a written examination, a demonstration of clinical skills under direct observation, case-based evaluation, and review of the documentation produced during the practicum. The certificate is issued when competency has been demonstrated, and not before.

Objectives All ten

The clinical sessions

Three afternoons in the infusion suite.

The clinical sessions are where the morning material is performed. No patients are involved: participants work on one another, under the direct supervision of a senior KRI clinician.

Day 1 · afternoon

The clinical skills lab

A complete infusion encounter walked end to end in the live suite: intake and the pre-infusion time-out, IV access and pump programming, airway assessment, monitoring and sedation scoring, and the discharge protocol, including 30 to 60 minutes of observation and written instructions.

Objectives 06 · 07
Day 2 · afternoon

The peer practicum begins

Participants pair up and perform a complete infusion for one another under direct supervision: evaluation, dose calculation, line placement, pump programming, monitoring and sedation scoring, documentation as it happens, and discharge. Two participants receive their infusion today; each session runs 1.5 to 2 hours.

Objectives 04 · 06 · 07 · 08
Day 3 · afternoon

The practicum continues, with precision medicine at the chair

The remaining two participants receive their infusions. The day’s precision-medicine material is applied directly: setting the target for the indication, adjusting for the individual, planning the series, and completing the full discharge protocol.

Objectives 03 · 04 · 08

Module 15

What the competency assessment involves.

The program is competency-based. A certificate is issued when a participant has demonstrated the objectives, across four parts:

Written examination

A 100-question examination covering pharmacology, patient selection, dosing, safety, regulation and documentation.

Observed clinical skills

Direct observation of the full infusion encounter during the practicum, from evaluation to discharge.

Case-based evaluation

Structured cases that test judgment: complex medication lists, comorbidity, non-response and adverse events.

Documentation review

Review of the records produced during the practicum against anesthesia-standard documentation.

KRI Trained and Certified Clinician badge

Graduates receive a certificate of training with a competency attestation setting out what was assessed and what was demonstrated, and may use the KRI Trained and Certified Clinician mark. It is a certificate from the Ketamine Research Institute. It is not board certification and not an accreditation. More about the assessment and the credential →

After the four days

The curriculum continues through the mentorship year.

Case consultation

Direct access to the clinical team for dosing questions, complex cases and unexpected reactions.

Protocol and practice support

Help with protocols, equipment, documentation and the practical work of opening or rebuilding an infusion service.

Regulatory updates

Notice of state and federal developments that affect office-based ketamine practice.

Quarterly milestones

Checkpoints through the year, with a competency re-assessment at twelve months.

The mentorship year →

Reading

The references the modules draw on.

  1. Domino EF, Chodoff P, Corssen G. Clin Pharmacol Ther. 1965;6:279–291.
  2. Krystal JH, Karper LP, Seibyl JP, et al. Arch Gen Psychiatry. 1994;51(3):199–214.
  3. Berman RM, Cappiello A, Anand A, et al. Biol Psychiatry. 2000;47(4):351–354.
  4. Zarate CA Jr, Singh JB, Carlson PJ, et al. Arch Gen Psychiatry. 2006;63(8):856–864.
  5. Sanacora G, Frye MA, McDonald W, et al. JAMA Psychiatry. 2017;74(4):399–405.
  6. McInnes LA, Qian JJ, Gargeya RS, et al. J Affect Disord. 2022;301:486–495.
  7. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clin Pharmacokinet. 2016;55(9):1059–1077.
  8. Zanos P, Moaddel R, Morris PJ, et al. Pharmacol Rev. 2018;70(3):621–660.
  9. Li Y, Coller JK, Hutchinson MR, et al. Drug Metab Dispos. 2013;41(6):1264–1272.
  10. Murrough JW, Perez AM, Pillemer S, et al. Biol Psychiatry. 2013;74(4):250–256.
  11. Struys MMRF, De Smet T, Glen JB, et al. Anesth Analg. 2016;122(1):56–69.
  12. Clements JA, Nimmo WS. Br J Anaesth. 1981;53(1):27–30.
  13. Zarate CA Jr, Brutsche N, Laje G, et al. Biol Psychiatry. 2012;72(4):331–338.

The full reading library →

The curriculum in full

Download the curriculum overview.

Every module, the four days hour by hour, the clinical sessions, the competency assessment and the mentorship year, in a single document. Revision 5.1, October 2026.

Four places in each session

Four clinicians at a time, in Sarasota. We set the dates with each cohort rather than publishing a calendar. For current availability, call 800-850-6979 or email training@ketamineinstitute.com.